News

Nov 02
The cryptocurrency market digest (BTC, TON). Overview for 02.11.2022

The BTC paused again. On Wednesday, it mainly fluctuates near 20,507 USD. Investors are saving powers before the Federal Reserve System decides anything about the interest rate. The main forecast implies an increase by 75 base points to 4% annual. According to the CME, the probability of such a scenario is 86%. However, the main […]

Nov 02
Yen manages to remain stable. Overview for 02.11.2022

Japanese yen against the US dollar today is quite balanced. The current quote is 147.17. Today the minutes of the last meeting of the Bank of Japan have been published. It says that the Japanese economy is speeding up, and in the long run the weakness of the yen will augment overseas economic activity. Monetary […]

Nov 02
BTC miner CleanSpark scoops up thousands of miners amid ‘distressed markets’

Sustainability-focused Bitcoin (BTC) mining company CleanSpark has snapped up another 3,843 cryptocurrency miners amid a backdrop of mining industry consolidation. The $5.9 million purchase of the Antminer S19J Pro Bitcoin miners announced by the company on Nov. 1 came at a price of $15.50 per terahash — far cheaper than the current market price of […]

Nov 02
Singapore bank DBS uses DeFi to trade FX and state securities

Major Asian financial institution DBS Bank has applied DeFi technology for a project backed by the Monetary Authority of Singapore. 1009 Total views 19 Total shares DBS Bank, a major financial services group in Asia, is applying decentralized finance (DeFi) for a project backed by Singapore’s central bank. DBS has started a trading test of […]

Nov 02
Analyst sees ‘incremental positive’ in Wells Fargo regulatory update

Citi analyst Keith Horowitz said Tuesday that a fresh mention of ongoing discussions between Wells Fargo & Co WFC, +2.09% and federal banking regulators amounts to “incremental positive news” for the bank. Wells Fargo said in a Monday filing it’s in “resolution discussions” with the Consumer Financial Protection Bureau on a number of the regulator’s […]

Nov 02
Pfizer’s COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in Q3

Pfizer Inc.’s PFE, +3.14% COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the third quarter of the year, against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still expects $22 billion in sales for the year. The FactSet consensus is $22.5 billion. […]